Cardinal Health (CAH) Stock Price
Cardinal Health Price
Over the last 19 years Cardinal Health grew revenue by 5.8% annually, reaching 254.25 B USD. Earnings per share have grown at 1.7% per year over the last 19 years. For Cardinal Health, the net margin of 0.7% is up versus -0.5% a few years ago. At today's price the dividend yield works out to roughly 0.64%. The payout ratio is around 74% of earnings. The dividend has grown at 6.7% per year over the past 19 years. The consensus 12-month price target for Cardinal Health is 274.50 USD, about 15.5% above where the stock trades today. Of 24 analysts, 21 rate the stock a buy — an overall Buy consensus.
Cardinal Health stock price
Cardinal Health business model & stock analysis
Frequently asked questions about Cardinal Health
The business model of Cardinal Health Inc. revolves around providing essential services and solutions to healthcare organizations. As a renowned healthcare services and products company, Cardinal Health operates through various segments, including Pharmaceutical and Medical segments. The company distributes pharmaceuticals, medical and surgical products, along with offering innovative solutions and cost-effective services to healthcare providers. Cardinal Health also focuses on improving the efficiency and effectiveness of healthcare delivery, ultimately benefiting patients and healthcare professionals worldwide. With its extensive network and strong partnerships, Cardinal Health continues to excel in the healthcare industry and contribute to the overall well-being of communities.
Cardinal Health Inc is primarily active in the healthcare industry.
The main competitors of Cardinal Health Inc in the market include McKesson Corporation, AmerisourceBergen Corporation, and Owens & Minor Inc.
Cardinal Health Inc is a leading healthcare services and products company with a rich history and remarkable background. Established in 1971 in Dublin, Ohio, Cardinal Health initially focused on distributing pharmaceuticals to retail pharmacies. Over the years, it expanded its operations and services to include medical products, surgical supplies, and innovative healthcare technologies. Cardinal Health has gained extensive expertise in pharmaceutical sourcing, inventory management, and logistics, becoming a trusted partner in the healthcare industry. Today, it serves a diverse range of customers, including hospitals, pharmacies, clinics, and home healthcare providers. With its commitment to improving patient care and enhancing operational efficiency, Cardinal Health has established an impressive reputation within the healthcare sector.
Cardinal Health Inc has achieved several significant milestones throughout its history. One of its notable achievements includes being ranked #14 on the Fortune 500 list in 2020. The company has also been consistently recognized for its dedication to community involvement and sustainability efforts. In terms of its financial performance, Cardinal Health Inc has demonstrated consistent growth and profitability over the years. Moreover, the company has made strategic acquisitions and partnerships to expand its healthcare offerings and global reach. These milestones reflect Cardinal Health Inc's commitment to delivering innovative solutions and maintaining its position as a leader in the healthcare industry.
Cardinal Health Inc primarily operates in the United States.
Cardinal Health Inc represents values of integrity, excellence, and accountability in the healthcare industry. The company focuses on providing innovative solutions, quality products, and reliable services to meet the evolving needs of healthcare providers and patients. With a commitment to ethical business practices and corporate responsibility, Cardinal Health strives to improve the delivery of healthcare outcomes and enhance the overall well-being of communities. By fostering strong partnerships and embracing a patient-centric approach, Cardinal Health aims to drive positive change and improve the efficiency of healthcare operations.
Analysts currently set an average price target of 272.88 USD for the Cardinal Health stock (median: 274.50 USD), implying +14.8 % versus the latest price. The consensus is based on 24 analyst ratings.
24 analysts currently rate the Cardinal Health stock: 21 recommend buying, 3 holding and 0 selling.
Converted at the current exchange rate, the Cardinal Health share trades at 212.17 EUR (237.74 USD).
The Cardinal Health share (CAH) is listed on 7 stock exchanges, including: NYSE (CAH), London (0HTG.L), SIX (Zürich) (CLH.SW), Frankfurt (CLH.F), München (CLH.MU), Düsseldorf (CLH.DU).
The company Cardinal Health Inc is a pharmaceutical company that offers a wide range of services and products. The company is one of the leading healthcare providers worldwide and specializes in the areas of pharmacy, medical technology, and diagnostics. The company is particularly known for its pharmaceutical distribution services. Cardinal Health Inc supplies hospitals, pharmacies, and other healthcare facilities worldwide with pharmaceutical products. Additionally, the company also offers logistics and consulting services in the pharmaceutical industry. This includes support in the development and registration of pharmaceutical active ingredients as well as compliance consulting. Another pillar of the company is the development and manufacturing of medical products. Cardinal Health Inc offers a wide range of medical products, including consumables for medical applications and special medical technology. This includes devices for surgical procedures, diagnostic systems, and imaging systems. Another sector of Cardinal Health Inc is diagnostics. Under this area, the company offers a wide range of tests and analyses for medical facilities. This includes tests for cancer diagnostics, infection diagnostics, as well as determining genetic markers. The company places a strong emphasis on research and development. Cardinal Health Inc invests millions of dollars annually in the research and development of new products, as well as the improvement and optimization of existing products. The goal is always to offer customers innovative and future-oriented products. Another focus of the company is sustainability. Cardinal Health Inc aims to integrate sustainability and environmental protection into its daily business operations and to offer products and services that are not only economically but also environmentally and socially sustainable. Overall, Cardinal Health Inc offers a wide range of products and services for the pharmaceutical and medical industry. The different sectors complement each other optimally and enable the company to offer a comprehensive range. However, the company will continue to evolve and respond to the needs of customers in order to remain successful in the future.
The revenue of Cardinal Health is 254.25 B USD. This figure is based on current financial data and reflects the company's business performance.
The profit of Cardinal Health is 1.71 B USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Cardinal Health is currently 32.87. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Cardinal Health stock.
The price-to-sales ratio (P/S) of Cardinal Health is currently 0.22. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Cardinal Health stock.
The Eulerpool Quality Score for Cardinal Health is 5/10.
The ISIN of Cardinal Health is US14149Y1082. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Cardinal Health is 880206. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Cardinal Health is CAH. The ticker symbol is used to trade Cardinal Health shares on the stock exchange.
Cardinal Health stock
Cardinal Health Peer Group
Cardinal Health Ticker
Cardinal Health FIGI
All fundamentals and in-depth analysis of Cardinal Health
Our stock analysis for Cardinal Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cardinal Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.